HLVX Stock Discussion

HilleVax, Inc. Description

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Vaccines Pediatrics Covid 19 Vaccine